Tag: Sage Therapeutics
Ping Identity Holding (PING) is launching a public follow-up offer of 6 million shares of common stock held by Vista Equity Partners affiliated mutual funds at $ 24.00 per share ...
Bien qu'une étude à un stade avancé du médicament ait été couronnée de succès, le bénéfice de la zuranolone semble être relativement faible.
Sage Therapeutics (SAGE) and Biogen (BIIB) announce that the Phase 3 WATERFALL study in patients with major depressive disorder (MDD) has achieved its primary endpoint of ...